MedTrace Logo

Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures

NCT01343160 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2021-04-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to generate clinical data to support the use of GORE® VIABIL® Biliary Endoprosthesis in the endoscopic and percutaneous treatment of benign biliary strictures.

Conditions

  • Biliary Strictures

Interventions

DEVICE

GORE® VIABIL® Biliary Endoprosthesis

Deployment of GORE® VIABIL® Biliary Endoprosthesis to the area of stricture

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Principal Investigators

  • Karel Caca, MD · Klinikum Ludwigsburg

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01343160 on ClinicalTrials.gov